D.E. Shaw & Co’s NorthView Acquisition Corporation Rights NVACR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-150,000
Closed -$7.67K 5003
2024
Q3
$7.67K Hold
150,000
﹤0.01% 4397
2024
Q2
$15.3K Hold
150,000
﹤0.01% 4286
2024
Q1
$21K Hold
150,000
﹤0.01% 4120
2023
Q4
$13.1K Hold
150,000
﹤0.01% 4096
2023
Q3
$25.5K Hold
150,000
﹤0.01% 3965
2023
Q2
$21K Hold
150,000
﹤0.01% 3961
2023
Q1
$25.5K Hold
150,000
﹤0.01% 4114
2022
Q4
$25.9K Hold
150,000
﹤0.01% 4502
2022
Q3
$11K Hold
150,000
﹤0.01% 4919
2022
Q2
$18K Hold
150,000
﹤0.01% 5038
2022
Q1
$21K Buy
+150,000
New +$25.2K ﹤0.01% 5328

Other funds holding NVACR

D.E. Shaw & Co's NVACR Position: Q4 2024 in Review

D.E. Shaw & Co sold out of NorthView Acquisition Corporation Rights (NVACR) in Q4 2024, closing a stake of 150,000 shares — an estimated $7.67K sold.

D.E. Shaw & Co first reported a position in NVACR in Q1 2022 and held it in 11 quarters. The position peaked at $25.9K in Q4 2022. 5 funds tracked by Wall St. Rank hold NVACR as of Q4 2024.

  • D.E. Shaw & Co reported no remaining NorthView Acquisition Corporation Rights position as of Q4 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 150,000 NorthView Acquisition Corporation Rights shares in Q4 2024, an estimated $7.67K.
  • D.E. Shaw & Co first reported a position in NorthView Acquisition Corporation Rights in Q1 2022 and held it in 11 quarters.
  • D.E. Shaw & Co's NorthView Acquisition Corporation Rights position peaked at $25.9K in Q4 2022.
  • 5 funds tracked by Wall St. Rank held NorthView Acquisition Corporation Rights as of Q4 2024.

Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.